{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:11:39Z","timestamp":1769631099802,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T00:00:00Z","timestamp":1349740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00228-012-1418-z","type":"journal-article","created":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T08:42:52Z","timestamp":1349685772000},"page":"779-787","source":"Crossref","is-referenced-by-count":15,"title":["Psychological and physiological effects of bupropion compared to methylphenidate after prolonged administration in healthy volunteers (NCT00285155)"],"prefix":"10.1007","volume":"69","author":[{"given":"Hugues","family":"Chevassus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Farret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Gagnol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire-Anne","family":"Pon\u00e7on","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarisse","family":"Roux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Galtier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,9]]},"reference":[{"issue":"1","key":"1418_CR1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/j.1875-9114.1984.tb03306.x","volume":"4","author":"SH Preskorn","year":"1984","unstructured":"Preskorn SH, Othmer SC (1984) Evaluation of bupropion hydrochloride: the first of a new class of atypical antidepressants. Pharmacotherapy 4(1):20\u201334","journal-title":"Pharmacotherapy"},{"key":"1418_CR2","doi-asserted-by":"crossref","unstructured":"Hughes JR, Stead LF, Lancaster T (2007) Antidepressants for smoking cessation. Cochrane Database Syst Rev (1):CD000031","DOI":"10.1002\/14651858.CD000031.pub3"},{"issue":"9","key":"1418_CR3","first-page":"395","volume":"56","author":"JA Ascher","year":"1995","unstructured":"Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, Golden RN, Martin P, Potter WZ, Richelson E et al (1995) Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 56(9):395\u2013401","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"1418_CR4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-3565(25)32266-4","volume":"215","author":"BR Cooper","year":"1980","unstructured":"Cooper BR, Hester TJ, Maxwell RA (1980) Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J Pharmacol Exp Ther 215(1):127\u2013134","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"1418_CR5","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.biocel.2009.05.015","volume":"41","author":"HR Arias","year":"2009","unstructured":"Arias HR (2009) Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions? Int J Biochem Cell Biol 41(11):2098\u20132108","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"1418_CR6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s002130050044","volume":"148","author":"P Munzar","year":"2000","unstructured":"Munzar P, Goldberg SR (2000) Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology (Berl) 148(2):209\u2013216","journal-title":"Psychopharmacology (Berl)"},{"issue":"1\u20132","key":"1418_CR7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drugalcdep.2008.09.006","volume":"100","author":"CM Reichel","year":"2009","unstructured":"Reichel CM, Murray JE, Grant KM, Bevins RA (2009) Bupropion attenuates methamphetamine self-administration in adult male rats. Drug Alcohol Depend 100(1\u20132):54\u201362","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1418_CR8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF02245920","volume":"102","author":"RJ Lamb","year":"1990","unstructured":"Lamb RJ, Griffiths RR (1990) Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine. Psychopharmacology (Berl) 102(2):183\u2013190","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"1418_CR9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0022-3565(25)20689-9","volume":"251","author":"J Bergman","year":"1989","unstructured":"Bergman J, Madras BK, Johnson SE, Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251(1):150\u2013155","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"1418_CR10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.bjp.0707151","volume":"150","author":"P Bredeloux","year":"2007","unstructured":"Bredeloux P, Dubuc I, Costentin J (2007) Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission. Br J Pharmacol 150(6):711\u2013719","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1418_CR11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2125.1983.tb01512.x","volume":"15","author":"MJ Hamilton","year":"1983","unstructured":"Hamilton MJ, Smith PR, Peck AW (1983) Effects of bupropion, nomifensine and dexamphetamine on performance, subjective feelings, autonomic variables and electroencephalogram in healthy volunteers. Br J Clin Pharmacol 15(3):367\u2013374","journal-title":"Br J Clin Pharmacol"},{"issue":"5 Pt 2","key":"1418_CR12","first-page":"202","volume":"44","author":"AW Peck","year":"1983","unstructured":"Peck AW, Hamilton M (1983) Psychopharmacology of bupropion in normal volunteers. J Clin Psychiatry 44(5 Pt 2):202\u2013205","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"1418_CR13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1037\/1064-1297.6.1.32","volume":"6","author":"CR Rush","year":"1998","unstructured":"Rush CR, Kollins SH, Pazzaglia PJ (1998) Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans. Exp Clin Psychopharmacol 6(1):32\u201344","journal-title":"Exp Clin Psychopharmacol"},{"issue":"5","key":"1418_CR14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00004583-199505000-00017","volume":"34","author":"LL Barrickman","year":"1995","unstructured":"Barrickman LL, Perry PJ, Allen AJ, Kuperman S, Arndt SV, Herrmann KJ, Schumacher E (1995) Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34(5):649\u2013657","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"1418_CR15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1176\/appi.ajp.158.2.282","volume":"158","author":"TE Wilens","year":"2001","unstructured":"Wilens TE, Spencer TJ, Biederman J, Girard K, Doyle R, Prince J, Polisner D, Solhkhah R, Comeau S, Monuteaux MC, Parekh A (2001) A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 158(2):282\u2013288","journal-title":"Am J Psychiatry"},{"issue":"3","key":"1418_CR16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0091-3057(01)00464-6","volume":"68","author":"SH Kollins","year":"2001","unstructured":"Kollins SH, MacDonald EK, Rush CR (2001) Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol Biochem Behav 68(3):611\u2013627","journal-title":"Pharmacol Biochem Behav"},{"key":"1418_CR17","unstructured":"OMS (1993) Troubles mentaux et troubles deu comportement. Description clinique et directives pour le diagnostic. In: Classification Internationale des Maladies, Dixi\u00e8me r\u00e9vision (CIM-10). Masson, Paris"},{"issue":"2","key":"1418_CR18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cpt1971122part1245","volume":"12","author":"WR Martin","year":"1971","unstructured":"Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12(2):245\u2013258","journal-title":"Clin Pharmacol Ther"},{"key":"1418_CR19","unstructured":"McNair D, Lorr M, Droppleman LF (1971\/1992) Manual for the Profile of Mood States. Edits\/Educational ans Industrial Testing Service, San Diego"},{"issue":"5","key":"1418_CR20","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/1097-4679(198409)40:5<1270::AID-JCLP2270400526>3.0.CO;2-7","volume":"40","author":"JC Norcross","year":"1984","unstructured":"Norcross JC, Guadagnoli E, Prochaska JO (1984) Factor structure of the Profile of Mood States (POMS): two partial replications. J Clin Psychol 40(5):1270\u20131277","journal-title":"J Clin Psychol"},{"issue":"21","key":"1418_CR21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0028-3908(71)90039-6","volume":"10","author":"H Norris","year":"1971","unstructured":"Norris H (1971) The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology 10(21):181\u2013191","journal-title":"Neuropharmacology"},{"key":"1418_CR22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2044-8341.1974.tb02285.x","volume":"47","author":"A Bond","year":"1974","unstructured":"Bond A, Lader M (1974) Use Of Analog Scales In Rating Subjective Feelings. British Journal Of Medical Psychology 47:211\u2013218","journal-title":"British Journal Of Medical Psychology"},{"issue":"2","key":"1418_CR23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00434408","volume":"71","author":"AC Parrott","year":"1980","unstructured":"Parrott AC, Hindmarch I (1980) The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review. Psychopharmacology (Berl) 71(2):173\u2013179","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"1418_CR24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2125.1980.tb01745.x","volume":"10","author":"I Hindmarch","year":"1980","unstructured":"Hindmarch I (1980) Psychomotor function and psychoactive drugs. Br J Clin Pharmacol 10(3):189\u2013209","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"1418_CR25","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0149-2918(03)80137-6","volume":"25","author":"F Ridout","year":"2003","unstructured":"Ridout F, Shamsi Z, Meadows R, Johnson S, Hindmarch I (2003) A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180\u00a0mg alone and with alcohol, with hydroxyzine hydrochloride 50\u00a0mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car. Clin Ther 25(5):1518\u20131538","journal-title":"Clin Ther"},{"key":"1418_CR26","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1002\/hup.470100904","volume":"10","author":"N Sherwood","year":"1995","unstructured":"Sherwood N (1995) Comparative Behavioural Toxicity of the Selective Serotonin Reuptake Inhibitors. Human Psychopharmacology 10:S159\u2013S162","journal-title":"Human Psychopharmacology"},{"issue":"2","key":"1418_CR27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00735818","volume":"47","author":"JM Smith","year":"1976","unstructured":"Smith JM, Misiak H (1976) Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects-a review. Psychopharmacologia 47(2):175\u2013182","journal-title":"Psychopharmacologia"},{"issue":"6","key":"1418_CR28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/h0054651","volume":"18","author":"JR Stroop","year":"1935","unstructured":"Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18(6):643\u2013662","journal-title":"J Exp Psychol"},{"key":"1418_CR29","volume-title":"A manual for the Wechsler Adult Intelligence Scale","author":"D Wechsler","year":"1955","unstructured":"Wechsler D (1955) A manual for the Wechsler Adult Intelligence Scale. The Psychological Corporation, New York"},{"issue":"3","key":"1418_CR30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00002512-199914030-00004","volume":"14","author":"M Simard","year":"1999","unstructured":"Simard M, van Reekum R (1999) Memory assessment in studies of cognition-enhancing drugs for Alzheimer\u2019s disease. Drugs Aging 14(3):197\u2013230","journal-title":"Drugs Aging"},{"issue":"4","key":"1418_CR31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1079\/BJN19950056","volume":"73","author":"A Raben","year":"1995","unstructured":"Raben A, Tagliabue A, Astrup A (1995) The reproducibility of subjective appetite scores. Br J Nutr 73(4):517\u2013530","journal-title":"Br J Nutr"},{"issue":"3","key":"1418_CR32","first-page":"233","volume":"23","author":"G Gobbi","year":"2003","unstructured":"Gobbi G, Slater S, Boucher N, Debonnel G, Blier P (2003) Neurochemical and psychotropic effects of bupropion in healthy male subjects. J Clin Psychopharmacol 23(3):233\u2013239","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"1418_CR33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00213-005-0128-y","volume":"182","author":"M Siepmann","year":"2005","unstructured":"Siepmann M, Werner K, Schindler C, Oertel R, Kirch W (2005) The effects of bupropion on cognitive functions in healthy subjects. Psychopharmacology (Berl) 182(4):597\u2013598","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"1418_CR34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s00406-006-0640-z","volume":"256","author":"AF Carvalho","year":"2006","unstructured":"Carvalho AF, Kohler CA, Cruz EP, Sturmer PL, Reichman BP, Barea BM, Izquierdo I, Chaves ML (2006) Acute treatment with the antidepressants bupropion and sertraline do not influence memory retrieval in man. Eur Arch Psychiatry Clin Neurosci 256(5):320\u2013325","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"5 Pt 2","key":"1418_CR35","first-page":"206","volume":"44","author":"JD Griffith","year":"1983","unstructured":"Griffith JD, Carranza J, Griffith C, Miller LL (1983) Bupropion: clinical assay for amphetamine-like abuse potential. J Clin Psychiatry 44(5 Pt 2):206\u2013208","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"1418_CR36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00436152","volume":"80","author":"L Miller","year":"1983","unstructured":"Miller L, Griffith J (1983) A comparison of bupropion, dextroamphetamine, and placebo in mixed-substance abusers. Psychopharmacology (Berl) 80(3):199\u2013205","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"1418_CR37","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.npp.1300979","volume":"31","author":"TF Newton","year":"2006","unstructured":"Newton TF, Roache JD, De La Garza R 2nd, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R (2006) Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology 31(7):1537\u20131544","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"1418_CR38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0376-8716(02)00053-4","volume":"67","author":"SH Heil","year":"2002","unstructured":"Heil SH, Holmes HW, Bickel WK, Higgins ST, Badger GJ, Laws HF, Faries DE (2002) Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Depend 67(2):149\u2013156","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"1418_CR39","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1037\/1064-1297.5.4.344","volume":"5","author":"C Bishop","year":"1997","unstructured":"Bishop C, Roehrs T, Rosenthal L, Roth T (1997) Alerting effects of methylphenidate under basal and sleep-deprived conditions. Exp Clin Psychopharmacol 5(4):344\u2013352","journal-title":"Exp Clin Psychopharmacol"},{"issue":"3","key":"1418_CR40","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00213-005-0102-8","volume":"182","author":"TF Newton","year":"2005","unstructured":"Newton TF, Roache JD, De La Garza R 2nd, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R (2005) Safety of intravenous methamphetamine administration during treatment with bupropion. Psychopharmacology (Berl) 182(3):426\u2013435","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"1418_CR41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4088\/JCP.v66n0215","volume":"66","author":"TE Wilens","year":"2005","unstructured":"Wilens TE, Hammerness PG, Biederman J, Kwon A, Spencer TJ, Clark S, Scott M, Podolski A, Ditterline JW, Morris MC, Moore H (2005) Blood pressure changes associated with medication treatment of adults with attention-deficit\/hyperactivity disorder. J Clin Psychiatry 66(2):253\u2013259","journal-title":"J Clin Psychiatry"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-012-1418-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-012-1418-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-012-1418-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:27:20Z","timestamp":1744259240000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-012-1418-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,9]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["1418"],"URL":"https:\/\/doi.org\/10.1007\/s00228-012-1418-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,9]]}}}